But isn't the UPLIST is Coming...
GNID the developer of patented autonomous fingerprint healthcare security products announced today that it has released the company's first commissioned research report that highlights the company's products, analyzes the specific healthcare sub-markets its products are designed for, and has an outperform rating with a 2016 targeted share price of $17.41
The needs of the many, outweigh the needs of the few, or the one.